Join Us for a joint Town Hall to learn about the STARS Clinical Trial
Thursday, April 21, 2022
3 pm ET | 2 pm CT | 1 pm MT | 12 pm PT
Dr. Robert Roebling, Senior Medical Director in Seizure Freedom Mission at UCB will provide an introduction and overview to the STARS clinical research study. The global Phase 3 trial is designed for people who experience prolonged epileptic seizures, lasting more than 3 minutes. It is testing an inhaler containing an investigational drug to see whether it could help people who experience prolonged epileptic seizures.
This webinar will be recorded. By registering you consent to the webinar being recorded and distributed in the future. If you do not wish to be on the recording, please keep your camera off throughout the presentation.